Evidence map›Paper›PMID 36455678›Full record

ReviewUrology2023

Long vs Short Acting Testosterone Treatments: A Look at the Risks.

Aaron A Gurayah, Alexandra Dullea, Alexander Weber, John M Masterson, Kajal Khodamoradi, Arslan I Mohamed, Ranjith Ramasamy

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. A Current Perspective on Delayed Puberty and Its ManagementJournal of clinical research in pediatric endocrinology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Aaron A GurayahUniversity of Miami Miller School of Medicine, Miami, FL.
Alexandra DulleaDepartment of Urology, University of Miami Miller School of Medicine, University of Miami, Miami, FL.
Alexander WeberUniversity of Miami Miller School of Medicine, Miami, FL.
John M MastersonDepartment of Surgery, Division of Urology, Cedars-Sinai Medical Center, Los Angeles, CA.
Kajal KhodamoradiDepartment of Urology, University of Miami Miller School of Medicine, University of Miami, Miami, FL.
Arslan I MohamedCUNY School of Medicine, New York, NY.
Ranjith RamasamyDepartment of Urology, University of Miami Miller School of Medicine, University of Miami, Miami, FL. Electronic address: ramasamy@miami.edu.
University of Miami · USCedars-Sinai Medical Center · USCUNY School of Law · US

Funding

Disease Modifying Treatment Using Combined Shockwave Therapy and Platelet Rich Plasma In Microvascular Erectile DysfunctionR01DK130991 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI IBRAHIM, EMAD · 2021 to 2023
$921k
NIDDK NIH HHS R01 DK130991
6 · The paper itself

Abstract

Prescriptions for testosterone therapy (TT) to treat testosterone deficiency have increased in recent years. The purpose of this review was to evaluate the risks of several treatment modalities to better counsel patients. Both short-acting and long-acting TT has been shown to restore normal serum testosterone levels and improve symptoms of testosterone deficiency. Short-acting pharmacology mimics normal physiology more closely than long-acting TT but requires multiple doses per day. Long-acting TT has a higher rate of patient adherence but is more likely to create supraphysiologic serum testosterone and pathologic sequelae.

Indexed as

Hormone Replacement TherapyTestosteroneHumansTestosterone

Identifiers

PMID36455678
PMCPMC9925408
OpenAlexW4310253621

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.